GlassScriptPhysician profile
Caleb H Springstenn
NPI 1366718801
$378.94
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.83 · 2020: $46.76 · 2023: $137 · 2024: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $104.91 | 2023-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $102.28 | 2023-2024 | Gardasil 9, Vaxelis, Proquad |
| Ironshore Pharmaceuticals INC. | $32.54 | 2020 | |
| Hologic Sales and Service, LLC | $24.12 | 2023 | Aptima |
| Novo Nordisk INC | $21.65 | 2024 | Wegovy |
| Cranial Technologies, INC | $16.96 | 2024 | Doc Band |
| Pfizer INC. | $16.57 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.41 | 2024 | Synjardy, Jardiance |
| Otsuka America Pharmaceutical, INC. | $15.45 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $14.22 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Springstenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.